In this paper, comparisons were conducted between the two largest categories of PD therapy to derive a conclusion. The findings indicate some rather surprising results, and prove that dopamine agonists might not be as useful in the treatment of Parkinson’s Disease as one might assume.
By: Samarth Keerthivasan